Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups

NCT04767464 is registered in ClinicalTrials.gov with Mary Radomski as lead sponsor.

NCT NCT04767464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04767464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups
Lead sponsor
Mary Radomski
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2021
Completion date
November 7, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasm